The Integrated Serosurveillance and Modelling in Kenya (I-SAM) study hosted a central engagement meeting on the utilization of clinical residual samples for serosurveillance on the 27th March 2026 Royal Tulip hotel, Nairobi.
The meeting brought together representatives from Jaramogi Oginga Odinga Teaching and Referral Hospital, Mama Lucy Kibaki Hospital, Kilifi, Kakamega, Machakos, Kiambu and Nakuru Counties Teaching and Referral Hospitals as well as representatives from the Ministry of Health’s Division of Disease Surveillance and Response (DDSR) and the National Vaccine and Immunization Program (NVIP).
The meeting aimed at informing participants about the proposed program on utilizing residual clinical samples for multi-pathogen serosurveillance, seeking their support, and identifying effective implementation strategies. The meeting also served as a platform for feedback findings on multi-pathogen serosurveillance from the Kenya Multi-site Serosurveillance (KEMIS) project.
This central stakeholder engagement meeting surfaced key insights for piloting multi-pathogen serosurveillance utilizing residual clinical samples, including effective strategies for achieving the target stratum-specific sample sizes and collecting associated metadata. Participants felt that this approach to serosurveillance can generate actionable public health evidence and has the potential to be included in the national disease surveillance protocol currently under revision.